Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators. Agnelli G, et al. Among authors: bazzan m. N Engl J Med. 2001 Jul 19;345(3):165-9. doi: 10.1056/NEJM200107193450302. N Engl J Med. 2001. PMID: 11463010 Free article. Clinical Trial.
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Santamaria MG, et al. Among authors: bazzan m. Thromb Res. 2005;116(4):301-6. doi: 10.1016/j.thromres.2004.12.012. Epub 2005 Jan 26. Thromb Res. 2005. PMID: 16038714
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.
Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: bazzan m. J Thromb Haemost. 2003 Aug;1(8):1730-3. doi: 10.1046/j.1538-7836.2003.00293.x. J Thromb Haemost. 2003. PMID: 12911585 Free article.
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.
Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Sorarù M, Mosca S. Verso M, et al. Among authors: bazzan m. J Clin Oncol. 2005 Jun 20;23(18):4057-62. doi: 10.1200/JCO.2005.06.084. Epub 2005 Mar 14. J Clin Oncol. 2005. PMID: 15767643 Clinical Trial.
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
Taliani MR, Becattini C, Agnelli G, Prandoni P, Moia M, Bazzan M, Salvi R, Ageno W, Guazzaloca G, Imberti D, Silingardi M, Poggio R; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: bazzan m. Thromb Haemost. 2009 Mar;101(3):596-8. Thromb Haemost. 2009. PMID: 19277429 No abstract available.
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.
Pesavento R, Filippi L, Palla A, Visonà A, Bova C, Marzolo M, Porro F, Villalta S, Ciammaichella M, Bucherini E, Nante G, Battistelli S, Muiesan ML, Beltramello G, Prisco D, Casazza F, Ageno W, Palareti G, Quintavalla R, Monti S, Mumoli N, Zanatta N, Cappelli R, Cattaneo M, Moretti V, Corà F, Bazzan M, Ghirarduzzi A, Frigo AC, Miniati M, Prandoni P; SCOPE Investigators. Pesavento R, et al. Among authors: bazzan m. Eur Respir J. 2017 May 25;49(5):1601980. doi: 10.1183/13993003.01980-2016. Print 2017 May. Eur Respir J. 2017. PMID: 28546279 Free article.
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis.
Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, Piana A, Santoro R, Duce R, Poli D, Martinelli I, Siragusa S, Barillari G, Cattaneo M, Vidili G, Carpenedo M, Rancan E, Giaretta I, Tosetto A. Ageno W, et al. Among authors: bazzan m. Thromb Res. 2014 Jun;133(6):1052-5. doi: 10.1016/j.thromres.2014.03.044. Epub 2014 Apr 1. Thromb Res. 2014. PMID: 24731559
115 results